Page last updated: 2024-10-17

2-methylcitric acid and Liver Neoplasms

2-methylcitric acid has been researched along with Liver Neoplasms in 1 studies

2-methylcitric acid: RN given refers to parent cpd

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sun, J3
Ding, J3
Shen, Q3
Wang, X3
Wang, M3
Huang, Y3
Zhang, X3
Zhu, H3
Zhang, F3
Wu, D3
Peng, M3
Zhang, Z3
Yuan, Y3
Li, W3
She, ZG3
Zhang, XJ3
Li, H3
Zhang, P3
Huang, Z3

Other Studies

1 other study available for 2-methylcitric acid and Liver Neoplasms

ArticleYear
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
    Journal of hepatology, 2023, Volume: 78, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice

2023
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
    Journal of hepatology, 2023, Volume: 78, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice

2023
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
    Journal of hepatology, 2023, Volume: 78, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice

2023
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
    Journal of hepatology, 2023, Volume: 78, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice

2023